December 20, 2014 6:51 AM ET


Company Overview of Inverseon, Inc.

Company Overview

As of August 30, 2012, Inverseon, Inc. was acquired by Invion Limited. Invion Limited, a clinical-stage drug development company, focuses on the treatments for anti-inflammatory diseases. It focuses on the development of treatments for asthma, chronic bronchitis, and lupus.

1701 Jackson Street

Suite 102

San Francisco, CA 94109

United States

Founded in 2004





Key Executives for Inverseon, Inc.

Inverseon, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Fabre-Kramer Pharmaceuticals, Inc. United States
Prestige Brands International, Inc. United States
Advanced Life Sciences, Inc. United States
Stason Animal Health, Inc. United States
Cedarburg Laboratories, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inverseon, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at